Eden Research

EDEN · AIM · Chemicals · mcap £19m · 2.3p

Beta Briefing, track record and bull & bear case are not ready for Eden Research yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 41 companies are already wired into a briefing: browse them.

Gresham House Asset Management Limited 19 Feb – 14 Apr · 2 notices

7.3% → 22.1%

share price at the notices 3.5–4.0p · now 2.3p 19 Feb 2026 14 Apr 2026

Octopus Investments Limited 14 Apr · 1 notice

8.4% → 11.4%

share price at the notices 3.5p · now 2.3p 14 Apr 2026

Unicorn Asset Management Limited 19 Feb – 16 Apr · 2 notices

4.3% → 7.5%

share price at the notices 3.6–4.0p · now 2.3p 19 Feb 2026 16 Apr 2026

Maven Capital Partners UK LLP 13 Apr · 1 notice

3.1% → 4.7%

share price at the notices 3.3p · now 2.3p 13 Apr 2026

Directors

No open-market share purchases by directors in 12 months.

other Eden Research plc announced that non-Executive Director Derek McAllan has stepped down from the Board with immediate effect due to ill health, after serving during a significant period of regulatory approvals and capital 27 May 2026

award Eden Research plc has granted 33,737,659 options under its Long-Term Incentive Plan to staff, including 7,101,189 to CEO Sean Smith and 5,334,928 to CFO Alex Abrey, with the remaining 21,301,542 issued to other employees 17 Sep 2026

Company filings. Not investment advice.